Infliximab, a chimeric monoclonal antibody, sold under the brand name Remicade among others, is a medication used to treat a number of autoimmune diseases...

of a monoclonal antibody to be approved worldwide was a biosimilar of infliximab in the EU in 2013. On March 6, 2015, the FDA approved the United States'...

not infectious. Treatments may include corticosteroids, ciclosporin, infliximab, or canakinumab. The disease was identified in 1930. It affects approximately...

1988, a monoclonal antibody called infliximab was discovered at New York University's School of Medicine. Infliximab works by binding to TNF, stopping...

disease A combination of azathioprine and infliximab treatment may be more effective than a single dose of infliximab to induce steroid-free remission for...

Inhibition of TNF effects can be achieved with a monoclonal antibody such as infliximab, adalimumab, certolizumab pegol, and golimumab, or with a circulating...

(disease-modifying antirheumatic drugs), monoclonal antibodies, such as infliximab and adalimumab, the TNF inhibitor etanercept, and methotrexate for moderate...

such as infliximab from binding antigen in a laboratory test. Specifically, neutralization occurs when the anti-drug antibody binds to infliximab's antigen...

Calcipotriol Calcipotriol plus betamethasone dipropionate ointment. Efalizumab Infliximab Golimumab Low dose methotrexate Intralesional corticosteroid injection...

anakinra, tocilizumab, cyclophosphamide, adalimumab, rituximab, and infliximab. Newer medications target interleukin-1 (IL-1), particularly IL-1β. A...